gene therapy - search results

Sumith A Kularatne of On Target Laboratories, LLC highlights cancer immunotherapy as the treatment of the year to target cancer cells

Writing on behalf of the Chartered Society of Physiotherapy, Dr. Bhanu Ramaswamy highlights how physiotherapy can help manage the symptoms of Parkinson’s

Dr. Franz E. Weber, University Zurich's Center of Dental Medicine discusses how personalised medicine can be used in bone regeneration.

A new class of nanotherapy blockades the genetic drive for multiple myeloma progression. Gregory M. Lanza and Michael H Tomasson, of Department of Medicine, Washington University School of Medicine explain... Multiple myeloma is malignancy of plasma cells that reside in the bone marrow and normally function as part of our immune defence...

Professor Michela Alessandra Denti of the Centre for Integrative Biology at the University of Trento outlines the work of her laboratory on genetic diseases and cancers The Laboratory of RNA Biology and Biotechnology at the Centre for Integrative Biology (CIBIO) of the University of Trento, Italy, is focusing on RNA...

Regenerative medicine and cell therapy can revolutionise healthcare. Kath Mackay and Michael Sullivan, Lead Technologists in Regenerative Medicine at the Technology Strategy Board outline the importance of the field. Innovation is essential in developing the next generation of medical treatments. As the global population grows and ages, healthcare providers will need...

Dr Michael Morrison discusses the use of advanced biological therapies, such as gene therapy, in treatment for a personalised approach.

When it comes to the field of diabetic retinopathy research, Dr Lalit Pukhrambam at Wayne State University is exploring ways to prevent blinding eye diseases due to diabetes by targeting a protein called thioredoxin-interacting protein (TXNIP). Gene therapy is, therefore, a promising option

Multiple breakthroughs in gene therapy offer new hope for patients with genetic blood disorder, most common in Middle Eastern, Mediterranean, South Asian and African populations

Taking steps to protect our hearing often falls low on people’s agenda, but hearing loss can have serious lifelong consequences.

Dr Deborah Lee of Dr Fox Online Pharmacy outlines the burden of osteoarthritis, how it can impact daily life, and emerging treatment options.

A new technique by researchers at Oregon Health & Science University (OHSU) could change the infertility treatment .

Dr Tracey Pollard from RNID, the charity which supports the 12 million people in the UK who are deaf, have hearing loss or tinnitus, talks us through the causes and impact of hearing loss and how RNID is working to improve research and related treatments in this field.

Gillian Molloy, Director of Market Access at AscellaHealth, examines the rare disease landscape in the UK, including progress in improving patient care and challenges in diagnostics and the development of new treatments.

I specialise in the study of difficult-to-treat malignancies with unmet clinical needs, with a particular focus in the neuro-oncology setting I have significant expertise in the development of advanced preclinical models of Glioblastoma (GBM), interrogation of tumour microenvironment contexts of vulnerability, development of novel pre-clinical radiomic pipelines and investigation of...

Here we explore the massive impact nucleic acid chemistry has had on the manufacture of synthetic DNA and RNA sequences whilst explaining the chemistry behind the chemical synthesis of DNA.

Diabetes can pose significant implications for individuals’ mental and physical wellbeing. While new research shows promise in supporting diabetes management and care, many challenges still remain. We discussed these with Beyond Type 1’s content strategist Dr Liz Kopco.

Keith Valentine, Chief Executive of Fight for Sight and Vision Foundation, shares how these newly merged organisations are driving efforts in sight loss research to improve patient care.

Eric Buckland, PhD of Translational Imaging Innovations, delves into how we can achieve better transparency, traceability, and reproducibility in AI/ML for ophthalmology and medicine.

I graduated from Nippon Medical School (NMS) in 1988 and worked as a resident in the Third Department of Internal Medicine at NMS Hospital for two years, specializing in haematology In 1990, I entered graduate school to conduct research on genetic　abnormalities in leukaemia and completed graduate studies in 1944. After...